Hypermethylation of MGMT Gene Promoter in Peripheral Blood Mononuclear Cells as a Noninvasive Biomarker for Colorectal Cancer Diagnosis
Background: Early colorectal cancer (CRC) diagnosis can drastically reduce CRC-related morbidity and mortality. In this regard, increasing attention is now being directed to DNA-based tests, especially the evaluation of methylation levels, to prioritize high-risk suspected persons for colonoscopy ex...
Main Authors: | Sara Azhdari, Fatemeh Khodabandehloo, Naeim Ehtesham, Seyed Amirhossein Mazhari, Javad Behroozi, Goli Siri |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2023-01-01
|
Series: | Advanced Biomedical Research |
Subjects: | |
Online Access: | http://www.advbiores.net/article.asp?issn=2277-9175;year=2023;volume=12;issue=1;spage=256;epage=256;aulast=Azhdari |
Similar Items
-
Clinical Implications of Promoter Hypermethylation in RASSF1A and MGMT in Retinoblastoma
by: Kwong Wai Choy, et al.
Published: (2005-03-01) -
Improved Pathologic response to chemoradiation in MGMT methylated locally advanced rectal cancer
by: Garrett L. Jensen, et al.
Published: (2023-09-01) -
MGMT Promoter Methylation: Prognostication beyond Treatment Response
by: Keyoumars Ashkan, et al.
Published: (2023-06-01) -
A systematic review of high impact CpG sites and regions for MGMT methylation in glioblastoma [A systematic review of MGMT methylation in GBM]
by: David Gibson, et al.
Published: (2024-03-01) -
TUSC3 methylation in peripheral blood cells as a biomarker for diagnosis of colorectal cancer
by: Goli Siri, et al.
Published: (2023-01-01)